226 related articles for article (PubMed ID: 19168710)
1. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
[TBL] [Abstract][Full Text] [Related]
2. A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
Wen D; Nong Y; Morgan JG; Gangurde P; Bielecki A; Dasilva J; Keaveney M; Cheng H; Fraser C; Schopf L; Hepperle M; Harriman G; Jaffee BD; Ocain TD; Xu Y
J Pharmacol Exp Ther; 2006 Jun; 317(3):989-1001. PubMed ID: 16525037
[TBL] [Abstract][Full Text] [Related]
3. IkappaB kinase-2-independent and -dependent inflammation in airway disease models: relevance of IKK-2 inhibition to the clinic.
Birrell MA; Wong S; Hardaker EL; Catley MC; McCluskie K; Collins M; Haj-Yahia S; Belvisi MG
Mol Pharmacol; 2006 Jun; 69(6):1791-800. PubMed ID: 16517756
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the NF-kappaB signalling pathway by ergolide, sesquiterpene lactone, in HeLa cells.
Chun JK; Seo DW; Ahn SH; Park JH; You JS; Lee CH; Lee JC; Kim YK; Han JW
J Pharm Pharmacol; 2007 Apr; 59(4):561-6. PubMed ID: 17430640
[TBL] [Abstract][Full Text] [Related]
5. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
Izmailova ES; Paz N; Alencar H; Chun M; Schopf L; Hepperle M; Lane JH; Harriman G; Xu Y; Ocain T; Weissleder R; Mahmood U; Healy AM; Jaffee B
Arthritis Rheum; 2007 Jan; 56(1):117-28. PubMed ID: 17195214
[TBL] [Abstract][Full Text] [Related]
6. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
Newton R; Holden NS; Catley MC; Oyelusi W; Leigh R; Proud D; Barnes PJ
J Pharmacol Exp Ther; 2007 May; 321(2):734-42. PubMed ID: 17322026
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
Mbalaviele G; Anderson G; Jones A; De Ciechi P; Settle S; Mnich S; Thiede M; Abu-Amer Y; Portanova J; Monahan J
J Pharmacol Exp Ther; 2006 Jun; 317(3):1044-53. PubMed ID: 16501068
[TBL] [Abstract][Full Text] [Related]
8. Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells.
Park KA; Byun HS; Won M; Yang KJ; Shin S; Piao L; Kim JM; Yoon WH; Junn E; Park J; Seok JH; Hur GM
Carcinogenesis; 2007 Jan; 28(1):71-80. PubMed ID: 16774932
[TBL] [Abstract][Full Text] [Related]
9. Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells.
Yemelyanov A; Gasparian A; Lindholm P; Dang L; Pierce JW; Kisseljov F; Karseladze A; Budunova I
Oncogene; 2006 Jan; 25(3):387-98. PubMed ID: 16170348
[TBL] [Abstract][Full Text] [Related]
10. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
[TBL] [Abstract][Full Text] [Related]
11. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
Fan S; Meng Q; Laterra JJ; Rosen EM
Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation.
Tak PP; Gerlag DM; Aupperle KR; van de Geest DA; Overbeek M; Bennett BL; Boyle DL; Manning AM; Firestein GS
Arthritis Rheum; 2001 Aug; 44(8):1897-907. PubMed ID: 11508443
[TBL] [Abstract][Full Text] [Related]
13. A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts.
Kishore N; Sommers C; Mathialagan S; Guzova J; Yao M; Hauser S; Huynh K; Bonar S; Mielke C; Albee L; Weier R; Graneto M; Hanau C; Perry T; Tripp CS
J Biol Chem; 2003 Aug; 278(35):32861-71. PubMed ID: 12813046
[TBL] [Abstract][Full Text] [Related]
14. Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells.
Wakamatsu K; Nanki T; Miyasaka N; Umezawa K; Kubota T
Arthritis Res Ther; 2005; 7(6):R1348-59. PubMed ID: 16277688
[TBL] [Abstract][Full Text] [Related]
15. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
Taggart CC; Cryan SA; Weldon S; Gibbons A; Greene CM; Kelly E; Low TB; O'neill SJ; McElvaney NG
J Exp Med; 2005 Dec; 202(12):1659-68. PubMed ID: 16352738
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.
Viatour P; Merville MP; Bours V; Chariot A
Trends Biochem Sci; 2005 Jan; 30(1):43-52. PubMed ID: 15653325
[TBL] [Abstract][Full Text] [Related]
17. beta-Carboline alkaloid suppresses NF-kappaB transcriptional activity through inhibition of IKK signaling pathway.
Yoon JW; Kang JK; Lee KR; Lee HW; Han JW; Seo DW; Kim YK
J Toxicol Environ Health A; 2005 Dec; 68(23-24):2005-17. PubMed ID: 16326420
[TBL] [Abstract][Full Text] [Related]
18. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
[TBL] [Abstract][Full Text] [Related]
19. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
[TBL] [Abstract][Full Text] [Related]
20. Initiation and termination of NF-kappaB signaling by the intracellular protozoan parasite Toxoplasma gondii.
Shapira S; Harb OS; Margarit J; Matrajt M; Han J; Hoffmann A; Freedman B; May MJ; Roos DS; Hunter CA
J Cell Sci; 2005 Aug; 118(Pt 15):3501-8. PubMed ID: 16079291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]